Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Hair analysis can show nutritional status and environmental exposure, with phosphorus being very stable in hair and differences found based on gender and conditions like depression and autism.

Men with frontal male pattern baldness may have a higher risk of gastric cancer.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

IGF2BP3 and other m6A-related genes are linked to keloid formation and could be potential treatment targets.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Chicken feather gene mutation helps understand human hair disorders.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

Hormonal status significantly affects women's skin health throughout their lives.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Women with PCOS have higher renin and d-dimer levels, especially if they have COVID-19.

Hair loss causes differ between men and women due to changes in hormone levels and inflammation-related pathways.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Women with different PCOS types have similar fertility treatment results.

Mandarin duck sail feathers change with seasons due to hormones and genetic regulation.